Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes

This study has been terminated.
Medpace, Inc.
Information provided by (Responsible Party):
AiCuris GmbH & Co.KG Identifier:
First received: August 3, 2012
Last updated: July 8, 2014
Last verified: August 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2013
  Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: July 8, 2014